{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:24:51Z","timestamp":1778747091893,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T00:00:00Z","timestamp":1547942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-018-1939-x","type":"journal-article","created":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T01:02:27Z","timestamp":1547946147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Motofumi","family":"Koguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-6552","authenticated-orcid":false,"given":"Yukiko","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ebashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Masuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,20]]},"reference":[{"key":"1939_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. Pituitary. 2005;8:3\u20136.","journal-title":"Pituitary"},{"key":"1939_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev. 2006;27:485\u2013534.","journal-title":"Endocr Rev"},{"key":"1939_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-14-0144","volume":"171","author":"A Tj\u00f6rnstrand","year":"2014","unstructured":"Tj\u00f6rnstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, Ros\u00e9n T, et al. The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011. Eur J Endocrinol. 2014;171:519\u201326.","journal-title":"Eur J Endocrinol"},{"key":"1939_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-14-0013","volume":"170","author":"D Maiter","year":"2014","unstructured":"Maiter D, Delgrange E. Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur J Endocrinol. 2014;170:213\u201327.","journal-title":"Eur J Endocrinol"},{"key":"1939_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/cen.12242","volume":"79","author":"AB Moraes","year":"2013","unstructured":"Moraes AB, Marques Dos Santos Silva C, Vieira Neto L, Gadelha MR. Giant prolactinomas: the therapeutic approach. Clin Endocrinol. 2013;79:447\u201356.","journal-title":"Clin Endocrinol"},{"key":"1939_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.00901.x","volume":"52","author":"KS Leong","year":"2000","unstructured":"Leong KS, Foy PM, Swift AC, Atkin SL, Hadden DR, MacFarlane IA. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin Endocrinol. 2000;52:43\u20139.","journal-title":"Clin Endocrinol"},{"key":"1939_CR7","first-page":"140020","volume":"2014","author":"JK Prague","year":"2014","unstructured":"Prague JK, Ward CL, Mustafa OG, Whitelaw BC, King A, Thomas NW, et al. Delayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma. Endocrinol Diabetes Metab Case Rep. 2014;2014:140020.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"1939_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF03401344","volume":"13","author":"L Papanastasiou","year":"2014","unstructured":"Papanastasiou L, Fountoulakis S, Pappa T, Liberopoulos K, Malliopoulos D, Markou A, et al. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene? Hormones. 2014;13:290\u20135.","journal-title":"Hormones"},{"key":"1939_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s11102-009-0179-x","volume":"14","author":"DK Dhanwal","year":"2011","unstructured":"Dhanwal DK, Sharma AK. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma. Pituitary. 2011;14:384\u20137.","journal-title":"Pituitary"},{"key":"1939_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1365-2265.2008.03364.x","volume":"70","author":"G Raverot","year":"2009","unstructured":"Raverot G, Jacob M, Jouanneau E, Delemer B, Vighetto A, Pugeat M, et al. Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. Clin Endocrinol. 2009;70:588\u201392.","journal-title":"Clin Endocrinol"},{"key":"1939_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11102-014-0558-9","volume":"18","author":"J Moles Herbera","year":"2015","unstructured":"Moles Herbera J, Rivero Celada D, Montejo Ga\u00f1an I, Fustero de Miguel D, Fuentes Uliaque C, Vela Mar\u00edn AC. Pons herniation into skull base after cabergoline therapy of giant prolactinoma. Pituitary. 2015;18:68\u201371.","journal-title":"Pituitary"},{"key":"1939_CR12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2265.2007.02759.x","volume":"66","author":"D Deepak","year":"2007","unstructured":"Deepak D, Daousi C, Javadpour M, MacFarlane IA. Macroprolactinomas and epilepsy. Clin Endocrinol. 2007;66:503\u20137.","journal-title":"Clin Endocrinol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1939-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T06:35:27Z","timestamp":1720938927000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1939-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,20]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1939"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1939-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,20]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"18"}}